ReviewNature protocols2026
Production of human blood-generating heart-forming organoids and sample preparation for advanced imaging.
Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Application of human induced pluripotent stem cells for tissue modeling and therapy: are we on track?Stem cells (Dayton, Ohio) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human pluripotent stem (hPS) cell-derived blood-generating heart-forming organoids (BG-HFOs) represent a highly structured in vitro model that recapitulates aspects of human cardiac, hematoendothelial and multiwave hematopoietic co-development. Our model offers novel insights into human development and represents a potent tool for disease modeling, drug testing and other advanced in vitro assays. Here we provide a detailed 14-d protocol for the generation of BG-HFOs, from the embedding of hPS cell-derived aggregates in Matrigel, directing cell differentiation via WNT pathway modulation and supplementation of cytokine cocktails required for hematoendothelial induction and maturation. The protocol is robust and applicable to different hPS cell lines. Proper formation and patterning of the multiple tissues present in the BG-HFOs can be assessed through techniques such as live-cell imaging, whole-mount immunofluorescence (IF) staining, flow cytometry and gene-expression analysis. The efficient generation of BG-HFOs requires hands-on experience with hPS cell culture and the simultaneous management of multiple medium-enriching growth factors and small molecules. We additionally highlight a simple, scalable method of sample preparation for the effective investigation of BG-HFO morphology via laser microscopy using common laboratory equipment. This Protocol requires basic skills in handling hazardous chemicals and limited experience in IF staining and laser microscopy. Our robust and fast method enables the whole-mount IF staining and clearing of large organoids (up to 4 mm in diameter) composed of multiple tissues (with different physical properties) such as BG-HFOs and other complex organoid models in 2.5 d. The described workflow can thus promote fast laser microscopy, thereby tackling a major challenge in the field.
Indexed as
Identifiers
41168363What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.